The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MagnetisMM-30: A phase 1b, open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM).
 
Alexander M. Lesokhin
Honoraria - ITeos Therapeutics; Janssen; Legend Biotech; Pfizer; Sanofi; SVB Leerink; SVB Leerink; Trillium Therapeutics
Consulting or Advisory Role - Arcellx; Pfizer; Trillium Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Pfizer (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Muhammed Saleem Raza
No Relationships to Disclose
 
Jorge Acosta
No Relationships to Disclose
 
Patrick Muller
No Relationships to Disclose
 
Ashleigh O'Connell
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer (Inst)
 
Anne Yver
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer (Inst)
 
Carolyn Lou
Employment - Pfizer
 
Gregory Finn
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer (Inst)